메뉴 건너뛰기




Volumn 7, Issue 10, 2010, Pages 565-581

Diagnosis and management of IBS

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; BULKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETROPIUM; DESIPRAMINE; DIPHENOXYLATE; ISPAGULA; LAXATIVE; LOPERAMIDE; LUBIPROSTONE; MACROGOL; MEBEVERINE; METHYLCELLULOSE; NORTRIPTYLINE; OTILONIUM BROMIDE; PINAVERIUM; PLACEBO; POLYCARBOPHIL CALCIUM; PROBIOTIC AGENT; RIFAXIMIN; SCOPOLAMINE; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; SPASMOLYTIC AGENT; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMEBUTINE; UNINDEXED DRUG;

EID: 77957726316     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2010.137     Document Type: Review
Times cited : (103)

References (141)
  • 1
    • 33646201684 scopus 로고    scopus 로고
    • Functional bowel disorders
    • Longstreth, G. F. et al. Functional bowel disorders. Gastroenterology 130, 1480-1491 (2006).
    • (2006) Gastroenterology , vol.130 , pp. 1480-1491
    • Longstreth, G.F.1
  • 2
    • 0036893761 scopus 로고    scopus 로고
    • AGA technical review on irritable bowel syndrome
    • DOI 10.1053/gast.2002.37095
    • Drossman, D. A., Camilleri, M., Mayer, E. A. & Whitehead, W. E. AGA technical review on irritable bowel syndrome. Gastroenterology 123, 2108-2131 (2002). (Pubitemid 35408332)
    • (2002) Gastroenterology , vol.123 , Issue.6 , pp. 2108-2131
    • Drossman, D.A.1    Camilleri, M.2    Mayer, E.A.3    Whitehead, W.E.4
  • 3
    • 0024661487 scopus 로고
    • Functional gut disorders and health care seeking behavior in an Italian non-patient population
    • Gaburri, M. et al. Functional gut disorders and health care seeking behavior in an Italian non-patient population. Recenti Prog. Med. 80, 241-244 (1989).
    • (1989) Recenti Prog. Med. , vol.80 , pp. 241-244
    • Gaburri, M.1
  • 4
    • 17944363484 scopus 로고    scopus 로고
    • Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: Comparison of Rome II versus previous criteria in a general population
    • Mearin, F. et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand. J. Gastroenterol. 36, 1155-1161 (2001).
    • (2001) Scand. J. Gastroenterol. , vol.36 , pp. 1155-1161
    • Mearin, F.1
  • 5
    • 0026546046 scopus 로고
    • Symptoms of irritable bowel syndrome in a British urban community: Consulters and nonconsulters
    • Heaton, K. W. et al. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology 102, 1962-1967 (1992).
    • (1992) Gastroenterology , vol.102 , pp. 1962-1967
    • Heaton, K.W.1
  • 6
    • 0026604673 scopus 로고
    • Irritable bowel syndrome in the general population
    • Jones, R. & Lydeard, S. Irritable bowel syndrome in the general population. BMJ 304, 87-90 (1992).
    • (1992) BMJ , vol.304 , pp. 87-90
    • Jones, R.1    Lydeard, S.2
  • 7
    • 0033672548 scopus 로고    scopus 로고
    • Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population
    • Kennedy, T. M. & Jones, R. H. Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population. Br. J. Surg. 87, 1658-1663 (2000).
    • (2000) Br. J. Surg. , vol.87 , pp. 1658-1663
    • Kennedy, T.M.1    Jones, R.H.2
  • 8
    • 0034124615 scopus 로고    scopus 로고
    • Irritable bowel syndrome in general practice: Prevalence, characteristics, and referral
    • Thompson, W. G., Heaton, K. W., Smyth, G. T. & Smyth, C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 46, 78-82 (2000).
    • (2000) Gut , vol.46 , pp. 78-82
    • Thompson, W.G.1    Heaton, K.W.2    Smyth, G.T.3    Smyth, C.4
  • 9
    • 1542344817 scopus 로고    scopus 로고
    • Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome
    • Coffin, B., Dapoigny, M., Cloarec, D., Comet, D. & Dyard, F. Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome. Gastroenterol. Clin. Biol. 28, 11-15 (2004).
    • (2004) Gastroenterol. Clin. Biol. , vol.28 , pp. 11-15
    • Coffin, B.1    Dapoigny, M.2    Cloarec, D.3    Comet, D.4    Dyard, F.5
  • 10
    • 0029125418 scopus 로고
    • Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time
    • Agreus, L., Svardsudd, K., Nyren, O. & Tibblin, G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 109, 671-680 (1995).
    • (1995) Gastroenterology , vol.109 , pp. 671-680
    • Agreus, L.1    Svardsudd, K.2    Nyren, O.3    Tibblin, G.4
  • 11
    • 0028278238 scopus 로고
    • The epidemiology of irritable bowel syndrome in a random population: Prevalence, incidence, natural history and risk factors
    • Kay, L., Jorgensen, T. & Jensen, K. H. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J. Intern. Med. 236, 23-30 (1994).
    • (1994) J. Intern. Med. , vol.236 , pp. 23-30
    • Kay, L.1    Jorgensen, T.2    Jensen, K.H.3
  • 12
    • 20044364384 scopus 로고    scopus 로고
    • Irritable bowel syndrome in developing countries-a disorder of civilization or colonization?
    • Gwee, K. A. Irritable bowel syndrome in developing countries-a disorder of civilization or colonization? Neurogastroenterol. Motil. 17, 317-324 (2005).
    • (2005) Neurogastroenterol. Motil , vol.17 , pp. 317-324
    • Gwee, K.A.1
  • 13
    • 0036678922 scopus 로고    scopus 로고
    • The epidemiology of irritable bowel syndrome in North America: A systematic review
    • Saito, Y. A., Schoenfeld, P. & Locke, G. R. 3rd. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am. J. Gastroenterol. 97, 1910-1915 (2002).
    • (2002) Am. J. Gastroenterol. , vol.97 , pp. 1910-1915
    • Saito, Y.A.1    Schoenfeld, P.2    Locke III, G.R.3
  • 14
    • 27744461018 scopus 로고    scopus 로고
    • Prevalence and demographics of irritable bowel syndrome: Results from a large web-based survey
    • Andrews, E. B. et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment. Pharmacol. Ther. 22, 935-942 (2005).
    • (2005) Aliment. Pharmacol. Ther. , vol.22 , pp. 935-942
    • Andrews, E.B.1
  • 15
    • 20444464327 scopus 로고    scopus 로고
    • Irritable bowel syndrome in the United States: Prevalence, symptom patterns and impact
    • Hungin, A. P., Chang, L., Locke, G. R., Dennis, E. H. & Barghout, V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment. Pharmacol. Ther. 21, 1365-1375 (2005).
    • (2005) Aliment. Pharmacol. Ther. , vol.21 , pp. 1365-1375
    • Hungin, A.P.1    Chang, L.2    Locke, G.R.3    Dennis, E.H.4    Barghout, V.5
  • 16
    • 33646189604 scopus 로고    scopus 로고
    • Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders
    • Chang, L. et al. Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology 130, 1435-1446 (2006).
    • (2006) Gastroenterology , vol.130 , pp. 1435-1446
    • Chang, L.1
  • 17
    • 34547586603 scopus 로고    scopus 로고
    • Guidelines on the irritable bowel syndrome: Mechanisms and practical management
    • Spiller, R. et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 56, 1770-1798 (2007).
    • (2007) Gut , vol.56 , pp. 1770-1798
    • Spiller, R.1
  • 18
    • 0035006761 scopus 로고    scopus 로고
    • Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: A critical review of the literature on symptom and psychosocial factors
    • Koloski, N. A., Talley, N. J. & Boyce, P. M. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am. J. Gastroenterol. 96, 1340-1349 (2001).
    • (2001) Am. J. Gastroenterol. , vol.96 , pp. 1340-1349
    • Koloski, N.A.1    Talley, N.J.2    Boyce, P.M.3
  • 19
    • 0032740098 scopus 로고    scopus 로고
    • The relationship between psychosocial parameters and outcome in irritable bowel syndrome
    • Creed, F. The relationship between psychosocial parameters and outcome in irritable bowel syndrome. Am. J. Med. 107, 74S-80S (1999).
    • (1999) Am. J. Med. , vol.107
    • Creed, F.1
  • 21
    • 0343371688 scopus 로고    scopus 로고
    • Irritable bowel syndrome, anxiety, and depression: What are the links?
    • Lydiard, R. B. Irritable bowel syndrome, anxiety, and depression: what are the links? J. Clin. Psychiatry 62 (Suppl. 8), 38-45 (2001).
    • (2001) J. Clin. Psychiatry , vol.62 , Issue.8 SUPPL. , pp. 38-45
    • Lydiard, R.B.1
  • 22
    • 0032796430 scopus 로고    scopus 로고
    • Fibromyalgia in the irritable bowel syndrome: Studies of prevalence and clinical implications
    • Sperber, A. D. et al. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am. J. Gastroenterol. 94, 3541-3546 (1999).
    • (1999) Am. J. Gastroenterol. , vol.94 , pp. 3541-3546
    • Sperber, A.D.1
  • 23
    • 0036202892 scopus 로고    scopus 로고
    • Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?
    • Whitehead, W. E., Palsson, O. & Jones, K. R. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 122, 1140-1156 (2002).
    • (2002) Gastroenterology , vol.122 , pp. 1140-1156
    • Whitehead, W.E.1    Palsson, O.2    Jones, K.R.3
  • 24
    • 0025092940 scopus 로고
    • Irritable bowel syndrome in women having diagnostic laparoscopy or hysterectomy. Relation to gynecologic features and outcome
    • Longstreth, G. F., Preskill, D. B. & Youkeles, L. Irritable bowel syndrome in women having diagnostic laparoscopy or hysterectomy. Relation to gynecologic features and outcome. Dig. Dis. Sci. 35, 1285-1290 (1990).
    • (1990) Dig. Dis. Sci. , vol.35 , pp. 1285-1290
    • Longstreth, G.F.1    Preskill, D.B.2    Youkeles, L.3
  • 26
    • 0035999159 scopus 로고    scopus 로고
    • Healthrelated quality of life among persons with irritable bowel syndrome: A systematic review
    • El-Serag, H. B., Olden, K. & Bjorkman, D. Healthrelated quality of life among persons with irritable bowel syndrome: a systematic review. Aliment. Pharmacol. Ther. 16, 1171-1185 (2002).
    • (2002) Aliment. Pharmacol. Ther. , vol.16 , pp. 1171-1185
    • El-Serag, H.B.1    Olden, K.2    Bjorkman, D.3
  • 27
    • 0033866061 scopus 로고    scopus 로고
    • The impact of irritable bowel syndrome on health-related quality of life
    • Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B. & Mayer, E. A. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 119, 654-660 (2000).
    • (2000) Gastroenterology , vol.119 , pp. 654-660
    • Gralnek, I.M.1    Hays, R.D.2    Kilbourne, A.3    Naliboff, B.4    Mayer, E.A.5
  • 28
    • 0031940237 scopus 로고    scopus 로고
    • Quality of life in persons with irritable bowel syndrome: Development and validation of a new measure
    • Patrick, D. L., Drossman, D. A., Frederick, I. O., DiCesare, J. & Puder, K. L. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig. Dis. Sci. 43, 400-411 (1998).
    • (1998) Dig. Dis. Sci. , vol.43 , pp. 400-411
    • Patrick, D.L.1    Drossman, D.A.2    Frederick, I.O.3    DiCesare, J.4    Puder, K.L.5
  • 29
    • 33751574668 scopus 로고    scopus 로고
    • Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: Baseline results from LOGIC (longitudinal outcomes study of gastrointestinal symptoms in Canada), a naturalistic study
    • Pare, P. et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Clin. Ther. 28, 1726-1735 (2006).
    • (2006) Clin. Ther. , vol.28 , pp. 1726-1735
    • Pare, P.1
  • 30
    • 3242666620 scopus 로고    scopus 로고
    • Clinical determinants of health-related quality of life in patients with irritable bowel syndrome
    • Spiegel, B. M. et al. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch. Intern. Med. 164, 1773-1780 (2004).
    • (2004) Arch. Intern. Med. , vol.164 , pp. 1773-1780
    • Spiegel, B.M.1
  • 31
    • 0032216679 scopus 로고    scopus 로고
    • Psychosocial moderators of quality of life in irritable bowel syndrome
    • Naliboff, B. D., Balice, G. & Mayer, E. A. Psychosocial moderators of quality of life in irritable bowel syndrome. Eur. J. Surg. Suppl. 57-59 (1998).
    • (1998) Eur. J. Surg. Suppl. , pp. 57-59
    • Naliboff, B.D.1    Balice, G.2    Mayer, E.A.3
  • 33
    • 0036234316 scopus 로고    scopus 로고
    • The burden of selected digestive diseases in the United States
    • Sandler, R. S. et al. The burden of selected digestive diseases in the United States. Gastroenterology 122, 1500-1511 (2002).
    • (2002) Gastroenterology , vol.122 , pp. 1500-1511
    • Sandler, R.S.1
  • 35
    • 19844368345 scopus 로고    scopus 로고
    • Impairment in work productivity and health-related quality of life in patients with IBS
    • Dean, B. B. et al. Impairment in work productivity and health-related quality of life in patients with IBS. Am. J. Manag. Care 11, S17-S26 (2005).
    • (2005) Am. J. Manag. Care , vol.11
    • Dean, B.B.1
  • 36
    • 0037344032 scopus 로고    scopus 로고
    • Irritable bowel syndrome, health care use, and costs: A US managed care perspective
    • Longstreth, G. F. et al. Irritable bowel syndrome, health care use, and costs: a US managed care perspective. Am. J. Gastroenterol. 98, 600-607 (2003).
    • (2003) Am. J. Gastroenterol. , vol.98 , pp. 600-607
    • Longstreth, G.F.1
  • 37
    • 27744572307 scopus 로고    scopus 로고
    • The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome
    • Spiegel, B. M., Kanwal, F., Naliboff, B. & Mayer, E. The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome. Am. J. Gastroenterol. 100, 2262-2273 (2005).
    • (2005) Am. J. Gastroenterol. , vol.100 , pp. 2262-2273
    • Spiegel, B.M.1    Kanwal, F.2    Naliboff, B.3    Mayer, E.4
  • 38
    • 2942587232 scopus 로고    scopus 로고
    • Irritable bowel syndrome and surgery: A multivariable analysis
    • Longstreth, G. F. & Yao, J. F. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 126, 1665-1673 (2004).
    • (2004) Gastroenterology , vol.126 , pp. 1665-1673
    • Longstreth, G.F.1    Yao, J.F.2
  • 39
    • 24044548959 scopus 로고    scopus 로고
    • New insights into the pathophysiology of irritable bowel syndrome: Implications for future treatments
    • Crowell, M. D., Harris, L., Jones, M. P. & Chang, L. New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments. Curr. Gastroenterol. Rep. 7, 272-279 (2005).
    • (2005) Curr. Gastroenterol. Rep. , vol.7 , pp. 272-279
    • Crowell, M.D.1    Harris, L.2    Jones, M.P.3    Chang, L.4
  • 40
    • 61949191989 scopus 로고    scopus 로고
    • Post-infectious irritable bowel syndrome following water contamination
    • Marshall, J. K. Post-infectious irritable bowel syndrome following water contamination. Kidney Int. Suppl. S42-S43 (2009).
    • (2009) Kidney Int. Suppl.
    • Marshall, J.K.1
  • 41
    • 0030068596 scopus 로고    scopus 로고
    • Psychometric scores and persistence of irritable bowel after infectious diarrhoea
    • Gwee, K. A. et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 347, 150-153 (1996).
    • (1996) Lancet , vol.347 , pp. 150-153
    • Gwee, K.A.1
  • 42
    • 65449165950 scopus 로고    scopus 로고
    • Postinfectious irritable bowel syndrome
    • Spiller, R. & Garsed, K. Postinfectious irritable bowel syndrome. Gastroenterology 136, 1979-1988 (2009).
    • (2009) Gastroenterology , vol.136 , pp. 1979-1988
    • Spiller, R.1    Garsed, K.2
  • 43
    • 0033056598 scopus 로고    scopus 로고
    • The role of psychological and biological factors in postinfective gut dysfunction
    • Gwee, K. A. et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 44, 400-406 (1999).
    • (1999) Gut , vol.44 , pp. 400-406
    • Gwee, K.A.1
  • 44
    • 0037378888 scopus 로고    scopus 로고
    • Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome
    • Gwee, K. A. et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 52, 523-526 (2003).
    • (2003) Gut , vol.52 , pp. 523-526
    • Gwee, K.A.1
  • 45
    • 67649537590 scopus 로고    scopus 로고
    • An evidence-based position statement on the management of irritable bowel syndrome
    • Brandt, L. J. et al. An evidence-based position statement on the management of irritable bowel syndrome. Am. J. Gastroenterol. 104 (Suppl. 1), S1-S35 (2009).
    • (2009) Am. J. Gastroenterol. , vol.104 , Issue.1 SUPPL.
    • Brandt, L.J.1
  • 46
    • 68349141680 scopus 로고    scopus 로고
    • Developing valid and reliable health utilities in irritable bowel syndrome: Results from the IBS PROOF Cohort
    • Spiegel, B. et al. Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort. Am. J. Gastroenterol. 104, 1984-1991 (2009).
    • (2009) Am. J. Gastroenterol. , vol.104 , pp. 1984-1991
    • Spiegel, B.1
  • 47
    • 0034072849 scopus 로고    scopus 로고
    • Further validation of the IBS-QOL: A disease-specific quality-of-life questionnaire
    • Drossman, D. A. et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am. J. Gastroenterol. 95, 999-1007 (2000).
    • (2000) Am. J. Gastroenterol. , vol.95 , pp. 999-1007
    • Drossman, D.A.1
  • 48
    • 33746098966 scopus 로고    scopus 로고
    • Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review
    • Park, M. I. & Camilleri, M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol. Motil. 18, 595-607 (2006).
    • (2006) Neurogastroenterol. Motil , vol.18 , pp. 595-607
    • Park, M.I.1    Camilleri, M.2
  • 49
    • 0035103853 scopus 로고    scopus 로고
    • Food-related gastrointestinal symptoms in the irritable bowel syndrome
    • Simren, M. et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 63, 108-115 (2001).
    • (2001) Digestion , vol.63 , pp. 108-115
    • Simren, M.1
  • 50
    • 33646169541 scopus 로고    scopus 로고
    • Functional abdominal pain syndrome
    • Clouse, R. E. et al. Functional abdominal pain syndrome. Gastroenterology 130, 1492-1497 (2006).
    • (2006) Gastroenterology , vol.130 , pp. 1492-1497
    • Clouse, R.E.1
  • 51
    • 0037280275 scopus 로고    scopus 로고
    • Symptoms across the menstrual cycle in women with irritable bowel syndrome
    • Heitkemper, M. M. et al. Symptoms across the menstrual cycle in women with irritable bowel syndrome. Am. J. Gastroenterol. 98, 420-430 (2003).
    • (2003) Am. J. Gastroenterol. , vol.98 , pp. 420-430
    • Heitkemper, M.M.1
  • 53
    • 0021265175 scopus 로고
    • A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease
    • Kruis, W. et al. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 87, 1-7 (1984).
    • (1984) Gastroenterology , vol.87 , pp. 1-7
    • Kruis, W.1
  • 54
    • 54049117694 scopus 로고    scopus 로고
    • Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?
    • Ford, A. C. et al. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA 300, 1793-1805 (2008).
    • (2008) JAMA , vol.300 , pp. 1793-1805
    • Ford, A.C.1
  • 55
    • 69949129305 scopus 로고    scopus 로고
    • Systematic review: Accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care
    • Jellema, P., van der Windt, D. A., Schellevis, F. G. & Van der Horst, H. E. Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment. Pharmacol. Ther. 30, 695-706 (2009).
    • (2009) Aliment. Pharmacol. Ther. , vol.30 , pp. 695-706
    • Jellema, P.1    Van Der Windt, D.A.2    Schellevis, F.G.3    Van Der Horst, H.E.4
  • 56
    • 0036320081 scopus 로고    scopus 로고
    • Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease
    • Tibble, J. A., Sigthorsson, G., Foster, R., Forgacs, I. & Bjarnason, I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 123, 450-460 (2002).
    • (2002) Gastroenterology , vol.123 , pp. 450-460
    • Tibble, J.A.1    Sigthorsson, G.2    Foster, R.3    Forgacs, I.4    Bjarnason, I.5
  • 57
    • 0032820119 scopus 로고    scopus 로고
    • Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome
    • Vanner, S. J. et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am. J. Gastroenterol. 94, 2912-2917 (1999).
    • (1999) Am. J. Gastroenterol. , vol.94 , pp. 2912-2917
    • Vanner, S.J.1
  • 58
    • 2342420236 scopus 로고    scopus 로고
    • Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia
    • Hammer, J., Eslick, G. D., Howell, S. C., Altiparmak, E. & Talley, N. J. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut 53, 666-672 (2004).
    • (2004) Gut , vol.53 , pp. 666-672
    • Hammer, J.1    Eslick, G.D.2    Howell, S.C.3    Altiparmak, E.4    Talley, N.J.5
  • 59
    • 54349119864 scopus 로고    scopus 로고
    • Diagnostic utility of alarm features for colorectal cancer: Systematic review and meta-analysis
    • Ford, A. C. et al. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut 57, 1545-1553 (2008).
    • (2008) Gut , vol.57 , pp. 1545-1553
    • Ford, A.C.1
  • 60
    • 0037429081 scopus 로고    scopus 로고
    • Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: A large multicenter study
    • Fasano, A. et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch. Intern. Med. 163, 286-292 (2003).
    • (2003) Arch. Intern. Med. , vol.163 , pp. 286-292
    • Fasano, A.1
  • 61
    • 0037043658 scopus 로고    scopus 로고
    • Inflammatory bowel disease
    • Podolsky, D. K. Inflammatory bowel disease. N. Engl. J. Med. 347, 417-429 (2002).
    • (2002) N. Engl. J. Med. , vol.347 , pp. 417-429
    • Podolsky, D.K.1
  • 62
    • 0037310758 scopus 로고    scopus 로고
    • Colorectal cancer screening and surveillance: Clinical guidelines and rationale-Update based on new evidence
    • Winawer, S. et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124, 544-560 (2003).
    • (2003) Gastroenterology , vol.124 , pp. 544-560
    • Winawer, S.1
  • 63
    • 77950520756 scopus 로고    scopus 로고
    • Is irritable bowel syndrome a diagnosis of exclusion?: A survey of primary care providers, gastroenterologists, and IBS experts
    • Spiegel, B. M., Farid, M., Esrailian, E., Talley, J. & Chang, L. Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts. Am. J. Gastroenterol. 105, 848-858 (2010).
    • (2010) Am. J. Gastroenterol. , vol.105 , pp. 848-858
    • Spiegel, B.M.1    Farid, M.2    Esrailian, E.3    Talley, J.4    Chang, L.5
  • 64
    • 65249188081 scopus 로고    scopus 로고
    • Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: Systematic review and meta-analysis
    • Ford, A. C. et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch. Intern. Med. 169, 651-658 (2009).
    • (2009) Arch. Intern. Med. , vol.169 , pp. 651-658
    • Ford, A.C.1
  • 65
    • 2942627745 scopus 로고    scopus 로고
    • Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: A cost-effectiveness analysis
    • Spiegel, B. M., DeRosa, V. P., Gralnek, I. M., Wang, V. & Dulai, G. S. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology 126, 1721-1732 (2004).
    • (2004) Gastroenterology , vol.126 , pp. 1721-1732
    • Spiegel, B.M.1    DeRosa, V.P.2    Gralnek, I.M.3    Wang, V.4    Dulai, G.S.5
  • 66
    • 34447099633 scopus 로고    scopus 로고
    • Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome
    • Wahnschaffe, U., Schulzke, J. D., Zeitz, M. & Ullrich, R. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 5, 844-850 (2007).
    • (2007) Clin. Gastroenterol. Hepatol. , vol.5 , pp. 844-850
    • Wahnschaffe, U.1    Schulzke, J.D.2    Zeitz, M.3    Ullrich, R.4
  • 67
    • 77950516479 scopus 로고    scopus 로고
    • The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: Results from a prospective, controlled US trial
    • Chey, W. D. et al. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am. J. Gastroenterol. 105, 859-865 (2010).
    • (2010) Am. J. Gastroenterol. , vol.105 , pp. 859-865
    • Chey, W.D.1
  • 68
    • 77950477581 scopus 로고    scopus 로고
    • Evaluating a bacterial hypothesis in IBS using a modification of Koch's postulates: Part 1
    • Pimentel, M. Evaluating a bacterial hypothesis in IBS using a modification of Koch's postulates: part 1. Am. J. Gastroenterol. 105, 718-721 (2010).
    • (2010) Am. J. Gastroenterol. , vol.105 , pp. 718-721
    • Pimentel, M.1
  • 69
    • 36549056637 scopus 로고    scopus 로고
    • Breath tests for gastrointestinal disease: The real deal or just a lot of hot air?
    • Saad, R. J. & Chey, W. D. Breath tests for gastrointestinal disease: the real deal or just a lot of hot air? Gastroenterology 133, 1763-1766 (2007).
    • (2007) Gastroenterology , vol.133 , pp. 1763-1766
    • Saad, R.J.1    Chey, W.D.2
  • 70
    • 34249790127 scopus 로고    scopus 로고
    • Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
    • DOI 10.1136/gut.2006.108712
    • Posserud, I., Stotzer, P. O., Bjornsson, E. S., Abrahamsson, H. & Simren, M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 56, 802-808 (2007). (Pubitemid 46854194)
    • (2007) Gut , vol.56 , Issue.6 , pp. 802-808
    • Posserud, I.1    Stotzer, P.-O.2    Bjornsson, E.S.3    Abrahamsson, H.4    Simren, M.5
  • 71
    • 77956181459 scopus 로고    scopus 로고
    • Abnormal breath testing in IBS: A meta-analysis
    • Shah, E. D., Basseri, R. J., Chong, K. & Pimentel, M. Abnormal breath testing in IBS: a meta-analysis. Dig. Dis. Sci. 55, 2441-2449 (2010).
    • (2010) Dig. Dis. Sci. , vol.55 , pp. 2441-2449
    • Shah, E.D.1    Basseri, R.J.2    Chong, K.3    Pimentel, M.4
  • 72
    • 62849121718 scopus 로고    scopus 로고
    • Use of serum biomarkers in a diagnostic test for irritable bowel syndrome
    • Lembo, A. J. et al. Use of serum biomarkers in a diagnostic test for irritable bowel syndrome. Aliment. Pharmacol. Ther. 29, 834-842 (2009).
    • (2009) Aliment. Pharmacol. Ther. , vol.29 , pp. 834-842
    • Lembo, A.J.1
  • 73
    • 0026636839 scopus 로고
    • The irritable bowel syndrome: Review and a graduated multicomponent treatment approach
    • Drossman, D. A. & Thompson, W. G. The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann. Intern. Med. 116, 1009-1016 (1992).
    • (1992) Ann. Intern. Med. , vol.116 , pp. 1009-1016
    • Drossman, D.A.1    Thompson, W.G.2
  • 74
    • 0033966708 scopus 로고    scopus 로고
    • The influence of older patient-physician communication on health and healthrelated outcomes
    • Stewart, M., Meredith, L., Brown, J. B. & Galajda, J. The influence of older patient-physician communication on health and healthrelated outcomes. Clin. Geriatr. Med. 16, 25-36, vii-viii (2000).
    • (2000) Clin. Geriatr. Med. , vol.16 , Issue.25-36
    • Stewart, M.1    Meredith, L.2    Brown, J.B.3    Galajda, J.4
  • 75
    • 67349163863 scopus 로고    scopus 로고
    • A focus group assessment of patient perspectives on irritable bowel syndrome and illness severity
    • Drossman, D. A. et al. A focus group assessment of patient perspectives on irritable bowel syndrome and illness severity. Dig. Dis. Sci. 54, 1532-1541 (2009).
    • (2009) Dig. Dis. Sci. , vol.54 , pp. 1532-1541
    • Drossman, D.A.1
  • 76
    • 76849096625 scopus 로고    scopus 로고
    • Irritable bowel syndrome patients' ideal expectations and recent experiences with healthcare providers: A national survey
    • Halpert, A. et al. Irritable bowel syndrome patients' ideal expectations and recent experiences with healthcare providers: a national survey. Dig. Dis. Sci. 55, 375-383 (2010).
    • (2010) Dig. Dis. Sci. , vol.55 , pp. 375-383
    • Halpert, A.1
  • 77
    • 34548128805 scopus 로고    scopus 로고
    • What patients know about irritable bowel syndrome (IBS) and what they would like to know. National survey on patient educational needs in IBS and development and validation of the patient educational needs questionnaire (PEQ)
    • Halpert, A. et al. What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educational Needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). Am. J. Gastroenterol. 102, 1972-1982 (2007).
    • (2007) Am. J. Gastroenterol. , vol.102 , pp. 1972-1982
    • Halpert, A.1
  • 79
    • 0026546070 scopus 로고
    • Oral disodium cromoglycate treatment on irritable bowel syndrome: An open study on 101 subjects with diarrheic type
    • Stefanini, G. F. et al. Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am. J. Gastroenterol. 87, 55-57 (1992).
    • (1992) Am. J. Gastroenterol. , vol.87 , pp. 55-57
    • Stefanini, G.F.1
  • 80
    • 0022653422 scopus 로고
    • Efficacy of oral disodium cromoglycate in patients with irritable bowel syndrome and positive skin prick tests to foods
    • Stefanini, G. F., Bazzocchi, G., Prati, E., Lanfranchi, G. A. & Gasbarrini, G. Efficacy of oral disodium cromoglycate in patients with irritable bowel syndrome and positive skin prick tests to foods. Lancet 1, 207-208 (1986).
    • (1986) Lancet , vol.1 , pp. 207-208
    • Stefanini, G.F.1    Bazzocchi, G.2    Prati, E.3    Lanfranchi, G.A.4    Gasbarrini, G.5
  • 81
  • 82
    • 0026078855 scopus 로고
    • Airway responsiveness to inhaled methacholine in patients with irritable bowel syndrome
    • White, A. M., Stevens, W. H., Upton, A. R., O'Byrne, P. M. & Collins, S. M. Airway responsiveness to inhaled methacholine in patients with irritable bowel syndrome. Gastroenterology 100, 68-74 (1991).
    • (1991) Gastroenterology , vol.100 , pp. 68-74
    • White, A.M.1    Stevens, W.H.2    Upton, A.R.3    O'Byrne, P.M.4    Collins, S.M.5
  • 84
    • 77349095495 scopus 로고    scopus 로고
    • A cytologic assay for diagnosis of food hypersensitivity in patients with irritable bowel syndrome
    • Carroccio, A. et al. A cytologic assay for diagnosis of food hypersensitivity in patients with irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 8, 254-260 (2010).
    • (2010) Clin. Gastroenterol. Hepatol. , vol.8 , pp. 254-260
    • Carroccio, A.1
  • 85
    • 33748804733 scopus 로고    scopus 로고
    • Fructose malabsorption and symptoms of irritable bowel syndrome: Guidelines for effective dietary management
    • Shepherd, S. J. & Gibson, P. R. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J. Am. Diet. Assoc. 106, 1631-1639 (2006).
    • (2006) J. Am. Diet. Assoc. , vol.106 , pp. 1631-1639
    • Shepherd, S.J.1    Gibson, P.R.2
  • 86
    • 0141516473 scopus 로고    scopus 로고
    • Comparison of digestibility and breath hydrogen gas excretion of fructo-oligosaccharide, galactosyl-sucrose, and isomalto-oligosaccharide in healthy human subjects
    • Oku, T. & Nakamura, S. Comparison of digestibility and breath hydrogen gas excretion of fructo-oligosaccharide, galactosyl-sucrose, and isomalto-oligosaccharide in healthy human subjects. Eur. J. Clin. Nutr. 57, 1150-1156 (2003).
    • (2003) Eur. J. Clin. Nutr. , vol.57 , pp. 1150-1156
    • Oku, T.1    Nakamura, S.2
  • 87
    • 76149141784 scopus 로고    scopus 로고
    • Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach
    • Gibson, P. R. & Shepherd, S. J. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J. Gastroenterol. Hepatol. 25, 252-258 (2010).
    • (2010) J. Gastroenterol. Hepatol. , vol.25 , pp. 252-258
    • Gibson, P.R.1    Shepherd, S.J.2
  • 88
    • 84863593225 scopus 로고    scopus 로고
    • Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: Systematic review and metaanalysis
    • Ford, A. C. et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and metaanalysis. BMJ 337, a2313 (2008).
    • (2008) BMJ , vol.337
    • Ford, A.C.1
  • 89
    • 70349090574 scopus 로고    scopus 로고
    • Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial
    • Bijkerk, C. J. et al. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ 339, b3154 (2009).
    • (2009) BMJ , vol.339
    • Bijkerk, C.J.1
  • 90
    • 33644915873 scopus 로고    scopus 로고
    • Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome
    • Khoshoo, V., Armstead, C. & Landry, L. Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 23, 191-196 (2006).
    • (2006) Aliment. Pharmacol. Ther. , vol.23 , pp. 191-196
    • Khoshoo, V.1    Armstead, C.2    Landry, L.3
  • 91
    • 79951538087 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial of polyethylene glycol effects on fasting and postprandial rectal sensitivity and symptoms in hypersensitive constipation-predominant irritable bowel syndrome
    • doi:10.1111/j.146301318.2009.01990.x
    • Awad, R. A. & Camacho, S. A randomized, double-blind, placebo-controlled trial of polyethylene glycol effects on fasting and postprandial rectal sensitivity and symptoms in hypersensitive constipation-predominant irritable bowel syndrome. Colorectal Dis. doi:10.1111/j.146301318.2009.01990.x.
    • Colorectal. Dis.
    • Awad, R.A.1    Camacho, S.2
  • 92
    • 40949131857 scopus 로고    scopus 로고
    • Clinical trial: Phase 2 study of lubiprostone for irritable bowel syndrome with constipation
    • Johanson, J. F., Drossman, D. A., Panas, R., Wahle, A. & Ueno, R. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Aliment. Pharmacol. Ther. 27, 685-696 (2008).
    • (2008) Aliment. Pharmacol. Ther. , vol.27 , pp. 685-696
    • Johanson, J.F.1    Drossman, D.A.2    Panas, R.3    Wahle, A.4    Ueno, R.5
  • 93
    • 58149103805 scopus 로고    scopus 로고
    • Clinical trial: Lubiprostone in patients with constipationassociated irritable bowel syndrome-results of two randomized, placebo-controlled studies
    • Drossman, D. A. et al. Clinical trial: lubiprostone in patients with constipationassociated irritable bowel syndrome-results of two randomized, placebo-controlled studies. Aliment. Pharmacol. Ther. 29, 329-341 (2009).
    • (2009) Aliment. Pharmacol. Ther. , vol.29 , pp. 329-341
    • Drossman, D.A.1
  • 94
    • 33847002358 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation
    • Lin, S. R. et al. A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation. World J. Gastroenterol. 13, 732-739 (2007).
    • (2007) World J. Gastroenterol. , vol.13 , pp. 732-739
    • Lin, S.R.1
  • 95
    • 43549127335 scopus 로고    scopus 로고
    • Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: A randomized controlled trial
    • Chey, W. D., Pare, P., Viegas, A., Ligozio, G. & Shetzline, M. A. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial. Am. J. Gastroenterol. 103, 1217-1225 (2008).
    • (2008) Am. J. Gastroenterol. , vol.103 , pp. 1217-1225
    • Chey, W.D.1    Pare, P.2    Viegas, A.3    Ligozio, G.4    Shetzline, M.A.5
  • 96
    • 67650455908 scopus 로고    scopus 로고
    • Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: Systematic review and metaanalysis
    • Ford, A. C. et al. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and metaanalysis. Am. J. Gastroenterol. 104, 1831-1843 (2009).
    • (2009) Am. J. Gastroenterol. , vol.104 , pp. 1831-1843
    • Ford, A.C.1
  • 97
    • 34249104574 scopus 로고    scopus 로고
    • Novartis suspends tegaserod sales at FDA's request
    • Thompson, C. A. Novartis suspends tegaserod sales at FDA's request. Am. J. Health Syst. Pharm. 64, 1020 (2007).
    • (2007) Am. J. Health Syst. Pharm. , vol.64 , pp. 1020
    • Thompson, C.A.1
  • 98
    • 0023083675 scopus 로고
    • Loperamide treatment of the irritable bowel syndrome
    • Hovdenak, N. Loperamide treatment of the irritable bowel syndrome. Scand. J. Gastroenterol. Suppl. 130, 81-84 (1987).
    • (1987) Scand. J. Gastroenterol. Suppl. , vol.130 , pp. 81-84
    • Hovdenak, N.1
  • 99
    • 0023087382 scopus 로고
    • Loperamide in treatment of irritable bowel syndrome-a double-blind placebo controlled study
    • Lavo, B., Stenstam, M. & Nielsen, A. L. Loperamide in treatment of irritable bowel syndrome-a double-blind placebo controlled study. Scand. J. Gastroenterol. Suppl. 130, 77-80 (1987).
    • (1987) Scand. J. Gastroenterol. Suppl. , vol.130 , pp. 77-80
    • Lavo, B.1    Stenstam, M.2    Nielsen, A.L.3
  • 100
    • 0029946003 scopus 로고    scopus 로고
    • A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome
    • Efskind, P. S., Bernklev, T. & Vatn, M. H. A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome. Scand. J. Gastroenterol. 31, 463-468 (1996).
    • (1996) Scand. J. Gastroenterol. , vol.31 , pp. 463-468
    • Efskind, P.S.1    Bernklev, T.2    Vatn, M.H.3
  • 101
    • 77950142037 scopus 로고    scopus 로고
    • Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health-care practitioners
    • Grundmann, O. & Yoon, S. L. Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners. J. Gastroenterol. Hepatol. 25, 691-699 (2010).
    • (2010) J. Gastroenterol. Hepatol. , vol.25 , pp. 691-699
    • Grundmann, O.1    Yoon, S.L.2
  • 102
    • 33646441324 scopus 로고    scopus 로고
    • Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: Systematic review of clinical trials and post-marketing surveillance data
    • Chang, L. et al. Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data. Am. J. Gastroenterol. 101, 1069-1079 (2006).
    • (2006) Am. J. Gastroenterol. , vol.101 , pp. 1069-1079
    • Chang, L.1
  • 103
    • 13744263696 scopus 로고    scopus 로고
    • A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS
    • Chang, L. et al. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS. Am. J. Gastroenterol. 100, 115-123 (2005).
    • (2005) Am. J. Gastroenterol. , vol.100 , pp. 115-123
    • Chang, L.1
  • 104
    • 8744229903 scopus 로고    scopus 로고
    • Long-term safety and efficacy of alosetron in women with severe diarrheapredominant irritable bowel syndrome
    • Chey, W. D. et al. Long-term safety and efficacy of alosetron in women with severe diarrheapredominant irritable bowel syndrome. Am. J. Gastroenterol. 99, 2195-2203 (2004).
    • (2004) Am. J. Gastroenterol. , vol.99 , pp. 2195-2203
    • Chey, W.D.1
  • 105
    • 77950520996 scopus 로고    scopus 로고
    • Ischemic colitis and complications of constipation associated with the use of alosetron under a risk management plan: Clinical characteristics, outcomes, and incidences
    • Chang, L., Tong, K. & Ameen, V. Ischemic colitis and complications of constipation associated with the use of alosetron under a risk management plan: clinical characteristics, outcomes, and incidences. Am. J. Gastroenterol. 105, 866-875 (2010).
    • (2010) Am. J. Gastroenterol. , vol.105 , pp. 866-875
    • Chang, L.1    Tong, K.2    Ameen, V.3
  • 106
    • 57249089713 scopus 로고    scopus 로고
    • Rifaximin for the treatment of diarrhea-associated irritable bowel syndrome: Short term treatment leading to long term sustained response
    • Lembo, A. et al. Rifaximin for the treatment of diarrhea-associated irritable bowel syndrome: short term treatment leading to long term sustained response. Gastroenterology 134 (Suppl. 1), A-545 (2008).
    • (2008) Gastroenterology , vol.134 , Issue.1 SUPPL.
    • Lembo, A.1
  • 107
    • 77953216139 scopus 로고    scopus 로고
    • Rifaximin treatment for 2 weeks provides acute and sustained relief over 12 weeks of IBS symptoms in nonconstipated irritable bowel syndrome: Results from 2 North American phase 3 trials (Target 1 and Target 2)
    • Pimentel, M. et al. Rifaximin treatment for 2 weeks provides acute and sustained relief over 12 weeks of IBS symptoms in nonconstipated irritable bowel syndrome: results from 2 North American phase 3 trials (Target 1 and Target 2). Gastroenterology 138 (Suppl. 1), S-64-S-65 (2010).
    • (2010) Gastroenterology , vol.138 , Issue.1 SUPPL.
    • Pimentel, M.1
  • 108
    • 33644912601 scopus 로고    scopus 로고
    • A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence
    • Sharara, A. I. et al. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am. J. Gastroenterol. 101, 326-333 (2006).
    • (2006) Am. J. Gastroenterol. , vol.101 , pp. 326-333
    • Sharara, A.I.1
  • 109
    • 67651222067 scopus 로고    scopus 로고
    • Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with rifaximin
    • Peralta, S., Cottone, C., Doveri, T., Almasio, P. L. & Craxi, A. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with rifaximin. World J. Gastroenterol. 15, 2628-2631 (2009).
    • (2009) World J. Gastroenterol. , vol.15 , pp. 2628-2631
    • Peralta, S.1    Cottone, C.2    Doveri, T.3    Almasio, P.L.4    Craxi, A.5
  • 110
    • 18944380179 scopus 로고    scopus 로고
    • Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon
    • Tursi, A., Brandimarte, G., Giorgetti, G. M. & Elisei, W. Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon. World J. Gastroenterol. 11, 2773-2776 (2005).
    • (2005) World J. Gastroenterol. , vol.11 , pp. 2773-2776
    • Tursi, A.1    Brandimarte, G.2    Giorgetti, G.M.3    Elisei, W.4
  • 111
    • 76549133482 scopus 로고    scopus 로고
    • A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome
    • Darvish-Damavandi, M., Nikfar, S. & Abdollahi, M. A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome. World J. Gastroenterol. 16, 547-553 (2010).
    • (2010) World J. Gastroenterol. , vol.16 , pp. 547-553
    • Darvish-Damavandi, M.1    Nikfar, S.2    Abdollahi, M.3
  • 112
    • 55649116852 scopus 로고    scopus 로고
    • Psychotropic agents in functional gastrointestinal disorders
    • Grover, M. & Drossman, D. A. Psychotropic agents in functional gastrointestinal disorders. Curr. Opin. Pharmacol. 8, 715-723 (2008).
    • (2008) Curr. Opin. Pharmacol. , vol.8 , pp. 715-723
    • Grover, M.1    Drossman, D.A.2
  • 113
    • 0031799285 scopus 로고    scopus 로고
    • Effects of tricyclic antidepressants on mechanosensitive pelvic nerve afferent fibers innervating the rat colon
    • DOI 10.1016/S0304-3959(98)00031-1, PII S0304395998000311
    • Su, X. & Gebhart, G. F. Effects of tricyclic antidepressants on mechanosensitive pelvic nerve afferent fibers innervating the rat colon. Pain 76, 105-114 (1998). (Pubitemid 28304946)
    • (1998) Pain , vol.76 , Issue.1-2 , pp. 105-114
    • Su, X.1    Gebhart, G.F.2
  • 114
    • 17644384100 scopus 로고    scopus 로고
    • Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome
    • Morgan, V., Pickens, D., Gautam, S., Kessler, R. & Mertz, H. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut 54, 601-607 (2005).
    • (2005) Gut , vol.54 , pp. 601-607
    • Morgan, V.1    Pickens, D.2    Gautam, S.3    Kessler, R.4    Mertz, H.5
  • 115
    • 61649089108 scopus 로고    scopus 로고
    • Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: Systematic review and meta-analysis
    • Ford, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. & Moayyedi, P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 58, 367-378 (2009).
    • (2009) Gut , vol.58 , pp. 367-378
    • Ford, A.C.1    Talley, N.J.2    Schoenfeld, P.S.3    Quigley, E.M.4    Moayyedi, P.5
  • 116
    • 10744226862 scopus 로고    scopus 로고
    • Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders
    • Drossman, D. A. et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 125, 19-31 (2003).
    • (2003) Gastroenterology , vol.125 , pp. 19-31
    • Drossman, D.A.1
  • 117
    • 47949097788 scopus 로고    scopus 로고
    • Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: Clinical efficacy, tolerability, feasibility
    • Lackner, J. M. et al. Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility. Clin. Gastroenterol. Hepatol. 6, 899-906 (2008).
    • (2008) Clin. Gastroenterol. Hepatol. , vol.6 , pp. 899-906
    • Lackner, J.M.1
  • 118
    • 77950866429 scopus 로고    scopus 로고
    • Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome
    • Lackner, J. M. et al. Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 8, 426-432 (2010).
    • (2010) Clin. Gastroenterol. Hepatol. , vol.8 , pp. 426-432
    • Lackner, J.M.1
  • 119
    • 77949610047 scopus 로고    scopus 로고
    • Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care
    • Reme, S. E., Kennedy, T., Jones, R., Darnley, S. & Chalder, T. Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care. J. Psychosom. Res. 68, 385-388 (2010).
    • (2010) J. Psychosom. Res. , vol.68 , pp. 385-388
    • Reme, S.E.1    Kennedy, T.2    Jones, R.3    Darnley, S.4    Chalder, T.5
  • 120
    • 0037370204 scopus 로고    scopus 로고
    • Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome
    • Drossman, D. A. et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology 124, 754-761 (2003).
    • (2003) Gastroenterology , vol.124 , pp. 754-761
    • Drossman, D.A.1
  • 121
    • 0026656251 scopus 로고
    • Prediction of outcome from cognitive-behavioral treatment of irritable bowel syndrome
    • Blanchard, E. B. et al. Prediction of outcome from cognitive-behavioral treatment of irritable bowel syndrome. Behav. Res. Ther. 30, 647-650 (1992).
    • (1992) Behav. Res. Ther. , vol.30 , pp. 647-650
    • Blanchard, E.B.1
  • 122
    • 31544462583 scopus 로고    scopus 로고
    • Prediction of treatment outcome among patients with irritable bowel syndrome treated with group cognitive therapy
    • Blanchard, E. B. et al. Prediction of treatment outcome among patients with irritable bowel syndrome treated with group cognitive therapy. Behav. Res. Ther. 44, 317-337 (2006).
    • (2006) Behav. Res. Ther. , vol.44 , pp. 317-337
    • Blanchard, E.B.1
  • 124
    • 0021679841 scopus 로고
    • Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome
    • Whorwell, P. J., Prior, A. & Faragher, E. B. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 2, 1232-1234 (1984).
    • (1984) Lancet , vol.2 , pp. 1232-1234
    • Whorwell, P.J.1    Prior, A.2    Faragher, E.B.3
  • 125
    • 0036117813 scopus 로고    scopus 로고
    • Hypnotherapy in irritable bowel syndrome: A large-scale audit of a clinical service with examination of factors influencing responsiveness
    • Gonsalkorale, W. M., Houghton, L. A. & Whorwell, P. J. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am. J. Gastroenterol. 97, 954-961 (2002).
    • (2002) Am. J. Gastroenterol. , vol.97 , pp. 954-961
    • Gonsalkorale, W.M.1    Houghton, L.A.2    Whorwell, P.J.3
  • 126
    • 47749090554 scopus 로고    scopus 로고
    • Review article: Probiotics and prebiotics in irritable bowel syndrome
    • Spiller, R. Review article: probiotics and prebiotics in irritable bowel syndrome. Aliment. Pharmacol. Ther. 28, 385-396 (2008).
    • (2008) Aliment. Pharmacol. Ther. , vol.28 , pp. 385-396
    • Spiller, R.1
  • 127
    • 65449172901 scopus 로고    scopus 로고
    • The utility of probiotics in the treatment of irritable bowel syndrome: A systematic review
    • Brenner, D. M., Moeller, M. J., Chey, W. D. & Schoenfeld, P. S. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am. J. Gastroenterol. 104, 1033-1049 (2009).
    • (2009) Am. J. Gastroenterol. , vol.104 , pp. 1033-1049
    • Brenner, D.M.1    Moeller, M.J.2    Chey, W.D.3    Schoenfeld, P.S.4
  • 128
    • 15744374565 scopus 로고    scopus 로고
    • Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles
    • O'Mahony, L. et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128, 541-551 (2005).
    • (2005) Gastroenterology , vol.128 , pp. 541-551
    • O'Mahony, L.1
  • 129
    • 33745569311 scopus 로고    scopus 로고
    • Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome
    • Whorwell, P. J. et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am. J. Gastroenterol. 101, 1581-1590 (2006).
    • (2006) Am. J. Gastroenterol. , vol.101 , pp. 1581-1590
    • Whorwell, P.J.1
  • 130
    • 42749099049 scopus 로고    scopus 로고
    • Acupuncture for treatment of irritable bowel syndrome
    • Art. No.: CD005111. doi:10.1002/14651858. CD005111.pub2
    • Lim, B. et al. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD005111. doi:10.1002/14651858. CD005111.pub2 (2006).
    • (2006) Cochrane Database of Systematic Reviews , Issue.4
    • Lim, B.1
  • 131
    • 33646252276 scopus 로고    scopus 로고
    • Acupuncture treatment in irritable bowel syndrome
    • Schneider, A. et al. Acupuncture treatment in irritable bowel syndrome. Gut 55, 649-654 (2006).
    • (2006) Gut , vol.55 , pp. 649-654
    • Schneider, A.1
  • 132
    • 67349162156 scopus 로고    scopus 로고
    • A treatment trial of acupuncture in IBS patients
    • Lembo, A. J. et al. A treatment trial of acupuncture in IBS patients. Am. J. Gastroenterol. 104, 1489-1497 (2009).
    • (2009) Am. J. Gastroenterol. , vol.104 , pp. 1489-1497
    • Lembo, A.J.1
  • 133
    • 43249121870 scopus 로고    scopus 로고
    • Components of placebo effect: Randomised controlled trial in patients with irritable bowel syndrome
    • Kaptchuk, T. J. et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 336, 999-1003 (2008).
    • (2008) BMJ , vol.336 , pp. 999-1003
    • Kaptchuk, T.J.1
  • 134
    • 33645518857 scopus 로고    scopus 로고
    • Herbal medicines for treatment of irritable bowel syndrome
    • Art. No.: CD004116. doi:10.1002/14651858. CD004116.pub2
    • Liu, J. P., Yang, M., Liu, Y. X., Wei, M. L. & Grimsgaard, S. Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD004116. doi:10.1002/14651858. CD004116.pub2 (2006).
    • (2006) Cochrane Database of Systematic Reviews , Issue.1
    • Liu, J.P.1    Yang, M.2    Liu, Y.X.3    Wei, M.L.4    Grimsgaard, S.5
  • 135
    • 59349091478 scopus 로고    scopus 로고
    • New treatments for irritable bowel syndrome in women
    • Adeyemo, M. A. & Chang, L. New treatments for irritable bowel syndrome in women. Womens Health (Lond. Engl.) 4, 605-622 (2008).
    • (2008) Womens Health (Lond. Engl.) , vol.4 , pp. 605-622
    • Adeyemo, M.A.1    Chang, L.2
  • 136
    • 57249103560 scopus 로고    scopus 로고
    • Challenges to the therapeutic pipeline for irritable bowel syndrome: End points and regulatory hurdles
    • Camilleri, M. & Chang, L. Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles. Gastroenterology 135, 1877-1891 (2008).
    • (2008) Gastroenterology , vol.135 , pp. 1877-1891
    • Camilleri, M.1    Chang, L.2
  • 137
    • 77957747609 scopus 로고    scopus 로고
    • The IBAT inhibitor A3309-a promising treatment option for patients with chronic idiopathic constipation (Cic)
    • Simren, M., Abrahamsson, H., Bajor, A. & Graffner, H. The IBAT inhibitor A3309-a promising treatment option for patients with chronic idiopathic constipation (Cic). Gastroenterology 138 (Suppl. 1), S223 (2010).
    • (2010) Gastroenterology , vol.138 , Issue.1 SUPPL.
    • Simren, M.1    Abrahamsson, H.2    Bajor, A.3    Graffner, H.4
  • 138
    • 77957745464 scopus 로고    scopus 로고
    • Dose-related effects of chenodeoxycholate on gastrointestinal and colonic transit and bowel function in female patients with constipation-predominant irritable bowel syndrome
    • Rao, A. et al. Dose-related effects of chenodeoxycholate on gastrointestinal and colonic transit and bowel function in female patients with constipation-predominant irritable bowel syndrome. Gastroenterology 138 (Suppl. 1), S224 (2010).
    • (2010) Gastroenterology , vol.138 , Issue.1 SUPPL.
    • Rao, A.1
  • 139
    • 77957743369 scopus 로고    scopus 로고
    • AST-120 (spherical carbon adsorbent) improves pain and bloating in a randomized, double-blind, placebo-controlled trial in patients with non-constipating irritable bowel syndrome (IBS)
    • Tack, J. et al. AST-120 (spherical carbon adsorbent) improves pain and bloating in a randomized, double-blind, placebo-controlled trial in patients with non-constipating irritable bowel syndrome (IBS). Gastroenterology 138, (Suppl. 1), S223 (2010).
    • (2010) Gastroenterology , vol.138 , Issue.1 SUPPL.
    • Tack, J.1
  • 140
    • 77957738218 scopus 로고    scopus 로고
    • LX1031, a novel locally-acting inhibitor of serotonin (5-HT) synthesis significantly improves symptoms in patients with IBS
    • Brown, P. et al. LX1031, a novel locally-acting inhibitor of serotonin (5-HT) synthesis significantly improves symptoms in patients with IBS. Gastroenterology 138 (Suppl. 1), S129 (2010).
    • (2010) Gastroenterology , vol.138 , Issue.1 SUPPL.
    • Brown, P.1
  • 141
    • 78650040146 scopus 로고    scopus 로고
    • GLP-1 playing the role of a gut regulatory compound
    • doi:10.1111/j.1748-1716.2010.02150.x
    • Hellstrom, P. M. GLP-1 playing the role of a gut regulatory compound. Acta Physiol. (Oxf.) doi:10.1111/j.1748-1716.2010.02150.x.
    • Acta Physiol. (Oxf.)
    • Hellstrom, P.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.